Board Approves the Separation of Aster's India and GCC Business, Subject to Regulatory and Corporavals Including Aster India's Shareholders' l. The Separation Plan Will Unlock Value for the Shareholders by Allow Both the India and GCC Businesss to Adopt A Market-Focused Strategy and CreateSustained Long-Term Growth.

Under theodial Plan, A Consortium Led by Fajr Capital Has Enteered Into A DEFINITIVEAREMENT to Acquire A M HealthCare FZC. Moopen Family Will Continue to Manage and Operate The Gcc Business Retaining A35% stake, on and from closing.

The Current Market Cap of the Combied India and GCC Business Stands at ~ USD $ 2.0 Billion. $ 1.7 Billion (Inr13, 540Cr [1]), and an equity value of us $1.0 Billion (INR 8,215Cr1).

Existing Shareholders to Remain with The Listed Indian Entity, Aster DM Healthcare Ltd. Upon Successful Completor OUS of Declaring Dividends to the Shareholders of Aster Dm Healthcare LTD from the Proceeeds, Subject to Approvals Required Under Law.

Azad Moopen Will Continue in his role as the fooder & chairman and will overalse both india and gcc businesssSesses, while Ms. Alisha Moopen will be promoted to the pos. ITion of Managing Director and Group CEO of the GCC Business. Dr. Nitish Shetty Will Continue AsThe CEO of the Aster Business in India.

-ASTER DM Healthcare ("ASTER"), One of the Larger and FASTSTEST-GROWING Integrated HealthCare PROVIDERS in GCC and India, HAS TODAY Received APPROMALS FROM Its Subsidial Affinity Holdings Private Limited ("Affinity) and Approval from itsTo sitate the india and GCC Business Into Two Distance and Standalone Entities. Under the Separation Plan, AFFINITY HAS ENTORED Into A DEFINITIVIVEAGREEMENT a consortium of Investors Led by Fajr Capital, a Sovereign-OWED Private Equity Firm Headquartered in the Uae, to InvestststIn Aster's Gcc Business. The fajr Capital -Led Consortium Also Includes Emirates Investment Authority, Al Dhow Holding Company OUP), Hana Investment Company (A Subsidary of Olayan Financing Company) and Wafra International Investment Company. The board of ofAFFINITY and ITS Representatives Who Negotiated the Transaction Formed A POSITIVE VIEW of the Favouric Valuation and Other Terms Offerd by the Fajr consortium.

ASTER DM Healthcare Was Established by Dr Azad Moopen in 1987 AS A Single Clinic in Dubai, Uae. The Company has sincencen to become a leading private HCARE PROVIDER, Offering A Full Spectrum of Primary, Secondary, Tertiary and Quaternary HealthCare Services that CaterTo the DIVERSE NEDS of its Patients. In India, Aster has a substantial and growing network in 5 South Indian States Throughs 19 Hospitals, 13 Clinics, 226 IES and 251 Patient Experience Center. Meanwhile, in the Gulf, Aster has developed a strongReputation and Presence, with 15 HOSPITALS, 118 Clinics and 276 Pharmacies Across the Uae, Saudi Arabia, QANAR, OMAN, BAHRAIN and Jordan.

Upon Completion, The Separation of the India and GCC Business SetInch Two Distinct Regional Healthcare Champions that Will Benefit from the Strategic and Fin Fin Ancial Flexibility to Focus on Growing Market Demand and the Prioroties of Patients.Dedicated Managent Teams and Will Also Benefit from a Dedicated Investor Base that Will Aidthth in the Indian and GCC Markets Respects, Both of WHI, ch hold significant geowth potential.

The GCC and India Healthcare Markets are distinct and have different growth dynamics, Warranting Different Business Strategies. Llion, India Will Remain A Priority Market in Aster Dm Healthcare LTD.'s Growth Journey. The Company Plans to Ramp Up UpBed CapaCity in India by Almost One-Thirds, by Adding More than 1500 Beds by Fy27. In the GCC, ASTER DM Healthcare FZC Will Bolster Itster ITS EXPANSIN Key Such as the uae and saudi arabia, while enability access to questionAnd comprehensive healthcare across physical and digital channels.

Post Completing, Dr. Azad Moopen Will Continue as the Founder & Chairman of Asster Overseeing Both India and GCC Entities. G Director and Group CEO of the GCC Business to Lead A Long-Term Strategy that Will UnlockValue as a Pure-PLAY GCC Operating CompanyJaipur Wealth Management. The Indian Entity will continue to be led by Dr. Nitish Shetty As Chief EXECUTIVEERER, Who Will Focus on The h of the india business, aimed at creation value for its shareholders.

EY and PWC Provended Independent Valuation Advice and Icici Securitys Provided Fairness Opinion for the Valuation Guidance. 'S Lawyers on the Transaction. Cyril AMarchand Mangaldas Was Aster's Lawyer on the Transaction.& Company and Credit Suisse acted as the sell-side advisors. HSBC Bank Middle East Ltd., Allen & Overy LLP and PwC acted on behalf of the Fajr Capital consortium.

Dr. Azad Moopen, Founder and Chairman of Aster Dm Healthcare Said: "The Strategic Decision to Segregate the India and GCC Operations Based on the Rational TO ESTAB Lish fair value for both Entities, Creating Two Pure-Play Geography Focused Entities that Are Able toLeverage the Growth Opportunities in their Respects. In India, We as promoters, Remain Commotted to Our Growth Plans and Hence Had Incarease Our Sta Ke TO 42% Earlier This Year. Major Instificational Shareholders Continue to Remain Investled, Reflecting Overall Confident in The Company's IndiasBusiness Model and Go-to-Market Strategy spanning all segments of the healthcare space. ""

"For the GCC, the FAJ CAPITAL HAS BeEEN Selected by the Board of Affinity as our Trusted Private Equity partner to lead, ss. We are confident given their demonstrated expertise and are excavated by their commitEXPANSION PITHIN the GCC's Dynamic Healthcare LandScape, Especially in Saudi Arabia. The Moopen Family Retain 35% Stake in the GCC Business. Ether, We ENVISION A FUTURE WHERE Aster's Business in the GCC Continues to Deliver Best-in-CLASS HealthCares toITS Patients Across the Region, UnderPinned by Fajr Capital's Strong Market Presence and Network. Alisha Will Lead on These Amber and Oversee The Next PHA se of our grewth trajectory in the gcc. "

MS. Alisha Moopen, who will server as the managing director and group Ceo of Aster's gcc business, "While the India Business of Aster DM HealthCare Has Made Ste Ste Ste Ste Ste Ste Ste Ste Ste Ste Ady Progress IN GROWING MULTIFOLD Within A Short Period of Time, The Segregation Will Enable OurGCC Operations to Seize a Significant Opportonity to UNLOCK VALUE Through ITS GEOGRAPHIC Expansion, DIVERSIFY Revenue Throughting Different Economic MENTS, While Expanding Into Tertiary Care and Digital Health. In our journey with the gcc businessAre Renown for their Expertise in Facilitation Business Growth. With our upcoming Expansions in the KSA Market, we are confident that their strategic count ld be of utmost value. ""

Mr. Iqbal Khan, CEO of Fajr Capital, SAID: "The Moopen Family has built a world-class company, With a Rich Legacy High Quality HealthCare To Mil lions of patients. LARGE FAMILY-LED PLATFORM Business is an Area where we haveDeep Experience and We Believe that Aster has significant portal to meet the gerying demand healthcares across the gulf region. FUL to the MOOPEN FAMILY for Their Trust and look forward to working with they, our consortium partners and the management team toAccelerate's ASBITIONS Through Continued Investment, Innovation and Expansion. "

Dr. Nitish Shetty, CEO of Aster DM Healthcare LTD. In India Said: "The Indian Healthcare Market Presents An University Ek Quality HealthCare Services at Affordable Cost. Aster Dm HealthCare Has Perfectd A Carefully Designed HealthCare Ecosystem, Spanning TheEntire Patient Life Cycle. The Company is uniquly posted to provate the. ND Investing Heavily in New-Age Technology Like Artificial Intelligence and Machine Learning to Bring Innovative Medical Solutions to The Forefront, Addressin GCritical HealthCare Challenges and Contributing to Improving Patient Outcomes. Our Five-Year Topline and Bottom-Line Cagr is a Testames of Thi. s Business ModelMumbai Stock Exchange. The RESTRUCTURING PROVIDES the Indian Balance Sheet with the Flexibility to Align ITS Capital Allocation Policies to Emergy GrowthOpportunities. "

The Separation Will Also Offer Aster INDIA An Opportonity to Potentially Expand ITS Instational Investor Base to Investors Who Are Manda Only or Majority Business. Shareholders of the India Business will benefit from better reporting and Financial Parameters for the Listen EntityThen, then

The Transaction is Subject to Shareholder Approval in India, Regulatory Compliances and Other Customaryments to Closing. Close by March 2024.Bangalore Investment